Due to fear of needles, many patients avoid injections. Needle-free injections can be the solution. iHealthNet, a US registered company, launched the first commercially available Needle-free Injection Technology (NFIT), the Biojector 2000, to the citizens of Bangladesh.
This device has FDA clearance and has been in use since 1987 in various parts of the world including USA, France, Malaysia, Philippines, Africa, Maldives, Sri Lanka and Australia. This eliminates the fear of pain and thus overcomes patients’ aversion to injections.
The Biojector 2000 (commonly known as B2000) is designed to deliver vaccines, insulin and other injectable medicine Intramuscularly (IM), Subcutaneously (SC) and Intradermally (ID) by pressurising the liquid dose in a chamber from which it is ejected through a small orifice of a syringe with sufficient force to penetrate human tissues. This device also provides dose accuracy, and eliminates cross contamination with a very negligible tissue trauma.
It is intended for use in clinics by medical personnel on humans, as well as self-use by patients. A Biojector B2000 can provide a minimum of 120,000 shots. Due to its cost effectiveness, recently many hospitals and clinics of Bangladesh have started to use this new needle-free injection.
